Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

November 2010 adverse event reports that FDA received in the month

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports received

In November 2010, FDA received 39,725 drug adverse event reports. In November 2009, FDA received 29,373.

In November 2010, FDA received 26,144 medical device reports. In November 2009, FDA received 22,320.

By drug reports received, November 2010 was number 5 of the 12 months of 2010. FDA received 38,228 drug reports a month on average in the 12 months before November 2010.

Receive date

A month is the month in which FDA first received the report, not the month of the event. A report about an event of an earlier year is in the month in which it came to FDA.

Data version

FAERS release of 29 Oct 2026. MAUDE release of 23 Oct 2026.

Drug reports, three years

Drug reports that FDA received each month, 36 months to November 2010
050,000100,000200820092010

Drugs in the reports

The table has the 94 drug pages with 100 or more reports in November 2010. The rows are in order of name. A drug page with fewer reports is not in the table.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports of November 2010 name as a suspect product, in order of name
DrugReports in the month
Accutane108
Aclasta178
Albuterol Sulfate Autohaler288
Aleve119
Altace172
Aspirin149
Avandia785
Avastin189
Avinza141
Avodart351
Avonex676
Bevacizumab115
Bosentan Tablet Unknown Us Mg182
BOTOX Cosmetic963
Botoxa145
Byetta123
Carboplatin115
Champix130
Chantix342
Cimzia1,068
Cisplatin180
Clozaril158
Cyclophosphamide215
Cymbalta182
Desvenlafaxine succinate122
Dexamethasone138
Dianeal530
Doxorubicin hydrochloride105
Duragesic-100183
Effexor151
Embeda117
Enbrel424
Epipen132
Etanercept104
Exjade285
Extraneal108
Flector446
Fluorouracil107
Forteo360
Fosamax238
Gleevec125
Heparin sodium115
Herceptin147
Humira448
Ibuprofen117
Kaletra125
Lantus210
Letairis162
Levaquin126
Levoxyl308
Lipitor455
Lisinopril103
Lyrica322
Mabthera121
Methotrexate217
Mirena339
Multaq116
Nexavar114
Nplate305
Nuvaring284
Onglyza215
OxyContin170
Paxil211
Prednisolone135
Prednisone167
Premarin133
Rebif352
Reclast101
Remicade587
Remodulin175
Revlimid368
Risperdal107
Rituximab137
Savella131
Seroquel184
Simcor680
Simvastatin123
Skelaxin170
Tikosyn160
Tiotropium bromide379
Toviaz124
Tysabri2,420
Tyvaso124
Velcade129
Viagra864
Victoza1,115
Wellbutrin124
Xeloda192
Yasmin175
Yaz196
Zoloft126
Zometa153
Zyprexa122
Zyvox149

Reaction terms in the reports

The table has the 91 reaction terms with 250 or more reports in November 2010. The rows are in order of name. One report can record more than one term.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Reaction terms that the drug reports of November 2010 record, in order of name
Reaction term (MedDRA) and plain meaningReports in the month
Abdominal discomfortstomach discomfort313
Abdominal painstomach or belly pain634
Abdominal pain upperupper stomach pain471
Alopeciahair loss285
Anaemialow red blood cells405
Anxietyanxiety689
Arthralgiajoint pain630
Astheniaweakness or lack of energy921
Atrial fibrillationan irregular heart rhythm277
Back painback pain490
Balance disorderproblems with balance309
Blood glucose increasedraised blood sugar reading446
Blood pressure increaseda raised blood pressure reading384
Cardiac failure congestivecongestive heart failure384
Cerebrovascular accidentstroke533
Chest discomfortchest discomfort268
Chest painchest pain552
Chillschills or shivering287
Condition aggravatedthe condition being treated got worse369
Confusional stateconfusion367
Constipationconstipation415
Convulsion483
Coughcough454
Deaththe patient died; cause not stated by this term2,034
Decreased appetitereduced appetite530
Deep vein thrombosisa blood clot in a deep vein272
Dehydrationdehydration351
Depressionlow mood735
Diarrhoealoose or frequent stools1,228
Disease progressionthe disease advanced256
Dizzinesslight-headedness or unsteadiness1,245
Drug exposure during pregnancythe medicine was taken during pregnancy550
Drug ineffectivethe medicine did not work as expected2,858
Drug interactionan interaction between medicines432
Dyspnoeashortness of breath1,255
Erythemaskin redness412
Falla fall796
Fatiguetiredness1,577
Feeling abnormalfeeling odd or not right518
Flushingsudden reddening or warmth of the skin490
Gait disturbancedifficulty walking549
Haemoglobin decreasedlow haemoglobin277
Headachehead pain1,540
Heart rate increaseda fast heart rate reading278
Hyperhidrosisexcessive sweating389
Hypersensitivityan allergic-type reaction374
Hypertensionhigh blood pressure488
Hypoaesthesianumbness419
Hypotensionlow blood pressure489
Infectionan infection, type not specified259
Influenza like illnessflu-like symptoms291
Injection site painpain where the injection was given317
Insomniadifficulty sleeping600
Loss of consciousnesspassing out355
Malaisegeneral feeling of being unwell856
Malignant neoplasm progression285
Memory impairmentmemory problems318
Multiple sclerosis relapsea flare of multiple sclerosis369
Muscle spasmsmuscle cramps427
Muscular weaknessmuscle weakness345
Myalgiamuscle pain376
Myocardial infarctionheart attack788
Nauseafeeling sick2,022
Oedema peripheralswelling of the legs, ankles or hands567
Overdosea dose above the recommended amount335
Painpain, site not specified987
Pain in extremitypain in an arm or leg608
Palpitationsawareness of the heartbeat351
Paraesthesiatingling or pins and needles435
Pneumonialung infection587
Product quality issuea problem with the product itself349
Pruritusitching730
Pulmonary embolisma blood clot in the lung383
Pyrexiafever873
Rashskin rash707
Renal failurekidney failure412
Renal failure acute341
Sepsisa severe body-wide response to infection312
Somnolencedrowsiness425
Suicidal ideationthoughts of suicide313
Syncopefainting274
Tachycardiafast heart rate253
Thrombocytopenialow platelets289
Tremorshaking476
Urinary tract infectionbladder or urinary infection371
Urticariahives374
Vision blurredblurred vision347
Vomitingbeing sick1,256
Weight decreasedweight loss647
Weight increasedweight gain392
Wrong technique in drug usage processthe medicine was used in the wrong way351

Devices in the reports

The table has the 61 device pages with 50 or more reports in November 2010. The rows are in order of name. A device page with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Device brand names that the device reports of November 2010 name, in order of name
Brand nameReports in the month
Access 2 Immunoassay System56
Accu-Chek Aviva Test Strips161
Accu-Chek Comfort Curve Test Strips82
Accu-Chek Compact Test Drum73
Accu-Chek Spirit149
Accu-Chek Spirit Combo94
Advanta Bed54
Animas Insulin Infusion Pump369
Automated Pd Set W/Cassette4 Prong208
Bravo91
Capsurefix Novus70
Colleague Cx Volumetric Infusion Pump Single Channel111
Colleague Cxe Volumetricinfusion Pump67
Colleague Single Channel Volumetric Pump Ce French50
Cypher Sirolimus-Eluting Coronary Stent54
Dextrus 413670
Durata Sts Optim Active Fixation75
Durata Sts Optim Active Fixation Df-4 Connector111
E Series Defibrillator73
Endeavor Sprint Rx Coronary Stent System66
Endopath Xcel65
Eon Mini Implantable Pulse Generator58
Greenlight Addstat239
Heart Start XL91
HiRes 90K56
Homechoice Cycler-Refurbished166
Infiniti Vision System Ozil80
Inratio179
Integrated Apd Set W/Cassette3-Prong199
LifeVest WCD 4000 System60
Ligamax-5mm78
M Series166
Mini-Cap Disconnect W/Pvp-1solution53
Octrode Percutaneous Lead84
OmniPod Insulin Pump66
One Touch Ping Glucose Management System239
Ot Ping Meter270
Ot Ultralink Meter260
Pd Cycler 110 Volt Home Choicepro Automated103
Perclose Proglide 6f Suture Mediated Closure Smc System256
Power Pro Ambulance Cot114
Precision?170
Programming Software79
Renal - Disposable228
Restore Ultra131
Riata Active Fixation100
Secure 3 Med/Surg Bed108
Sm204 M-Series W/Big Wheel79
Soletra83
Starclose Se Vascular Closure System114
Stenoscope52
Taxus Liberte Paclitaxel-Eluting Coronary Stent System117
Tendril Sdx90
Tendril St140
Tension Free Vaginal Tape59
Terumo Advanced Perfusion System 181
Terumo Cdi 500 Blood Parameter Monitor141
Totalcare151
Transtar Stretcher61
Unknown Depuy Asr Hip87
Xience V Everolimus Eluting Coronary Stent System118

Cite this page

Reported Reactions. November 2010: adverse event reports received by FDA. https://reportedreactions.com/month/2010-11/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The device counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Can the count for November 2010 change?

Yes. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases. This page has the count of the openFDA release of 29 Oct 2026: 39,725 drug reports.

Does a month with many reports mean that something occurred in that month?

Not by itself. The date is the date on which FDA received the report, not the date of the event. FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.